Found: 32
Select item for more details and to access through your institution.
Long-Acting Lipoglycopeptides: "Lineless Antibiotics" for Serious Infections in Persons Who Use Drugs.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 7, p. N.PAG, doi. 10.1093/ofid/ofz274
- By:
- Publication type:
- Article
Expanding the Role of the Patient-Centered Outcomes Research Institute: Reauthorization and Facilitating Value Assessments.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Cost comparison of asthma treatments in 12-week study: caution about matching and short observational follow-up.
- Published in:
- Multidisciplinary Respiratory Medicine, 2016, v. 11, p. 1, doi. 10.1186/s40248-016-0076-x
- By:
- Publication type:
- Article
Patient and Payer Preferences for Additional Value Criteria.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.690021
- By:
- Publication type:
- Article
Fasting Blood Glucose-A Missing Variable for GFR-Estimation in Type 1 Diabetes?
- Published in:
- PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0096264
- By:
- Publication type:
- Article
Patient and Family Outcomes of Community Neurologist Palliative Education and Telehealth Support in Parkinson Disease.
- Published in:
- JAMA Neurology, 2024, v. 81, n. 1, p. 39, doi. 10.1001/jamaneurol.2023.4260
- By:
- Publication type:
- Article
Cost-Effectiveness Uncertainty Analysis Methods: A Comparison of One-Way Sensitivity, Analysis of Covariance, and Expected Value of Partial Perfect Information.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Costs and outcomes associated with clopidogrel discontinuation in Medicare beneficiaries with acute coronary syndrome in the coverage gap.
- Published in:
- Drug, Healthcare & Patient Safety, 2012, v. 4, p. 67, doi. 10.2147/DHPS.S32473
- By:
- Publication type:
- Article
Long-term Survival and Cost-effectiveness Associated With Axicabtagene Ciloleucel vs Chemotherapy for Treatment of B-Cell Lymphoma.
- Published in:
- JAMA Network Open, 2019, v. 2, n. 2, p. e190035, doi. 10.1001/jamanetworkopen.2019.0035
- By:
- Publication type:
- Article
Potential Cardiovascular Events Avoided with Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared with Ezetimibe Alone in Patients with Atherosclerotic Cardiovascular Disease Taking Maximally Tolerated Statins.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 1, p. 67, doi. 10.1007/s40256-022-00552-7
- By:
- Publication type:
- Article
Long-term Survival and Value of Chimeric Antigen Receptor T-Cell Therapy for Pediatric Patients With Relapsed or Refractory Leukemia.
- Published in:
- JAMA Pediatrics, 2018, v. 172, n. 12, p. 1161, doi. 10.1001/jamapediatrics.2018.2530
- By:
- Publication type:
- Article
Considerations for Cost-effectiveness Analysis of Curative Pediatric Therapies.
- Published in:
- JAMA Pediatrics, 2018, v. 172, n. 5, p. 409, doi. 10.1001/jamapediatrics.2018.0049
- By:
- Publication type:
- Article
Using Real-World Data to Inform Value-Based Contracts for Cell and Gene Therapies in Medicaid.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 3, p. 319, doi. 10.1007/s40273-023-01335-x
- By:
- Publication type:
- Article
Incorporating Dynamic Pricing in Cost-Effectiveness Analysis: Are Known Unknowns Valuable?
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 3, p. 321, doi. 10.1007/s40273-022-01230-x
- By:
- Publication type:
- Article
Correction to: Contextual Considerations and Recommendations for Estimating the Value of Alzheimer's Disease Therapies.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Contextual Considerations and Recommendations for Estimating the Value of Alzheimer's Disease Therapies.
- Published in:
- PharmacoEconomics, 2021, v. 39, n. 10, p. 1101, doi. 10.1007/s40273-021-01079-6
- By:
- Publication type:
- Article
Toward Modified Impact Inventory Tables to Facilitate Patient-Centered Value Assessment.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
A Critical Appraisal and Recommendations for Cost-Effectiveness Studies of Poly(ADP-Ribose) Polymerase Inhibitors in Advanced Ovarian Cancer.
- Published in:
- PharmacoEconomics, 2020, v. 38, n. 11, p. 1201, doi. 10.1007/s40273-020-00949-9
- By:
- Publication type:
- Article
What Value Does the NCCN Affordability Rating Really Provide to Patients, Providers, and Society?
- Published in:
- 2020
- By:
- Publication type:
- journal article
Achieving Appropriate Model Transparency: Challenges and Potential Solutions for Making Value-Based Decisions in the United States.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Comment on "Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States".
- Published in:
- 2019
- By:
- Publication type:
- Letter
Cost-Effectiveness of Biological Asthma Treatments: A Systematic Review and Recommendations for Future Economic Evaluations.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Capsule Commentary on Duru et al., Adherence to Metformin, Statins, and ACE/ARBs Within the Diabetes Health Plan (DHP).
- Published in:
- 2015
- By:
- Publication type:
- journal article
Identifying Sepsis From Foodborne Hospitalization: Incidence and Hospitalization Cost by Pathogen.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 5, p. 857, doi. 10.1093/cid/ciab1045
- By:
- Publication type:
- Article
Clinical and Financial Impact of Pharmacy Services in the Intensive Care Unit: Pharmacist and Prescriber Perceptions.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 4, p. 401, doi. 10.1002/phar.1226
- By:
- Publication type:
- Article
Cost-Effectiveness of Asthma Step-Up Therapy as an Increased Dose of Extrafine-Particle Inhaled Corticosteroid or Add-On Long-Acting Beta-Agonist.
- Published in:
- Pulmonary Therapy, 2016, v. 2, n. 1, p. 73, doi. 10.1007/s41030-016-0014-2
- By:
- Publication type:
- Article
The 'e' in cost-effectiveness analyses. A case study of omalizumab efficacy and effectiveness for cost-effectiveness analysis evidence.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
The "E" in Cost-Effectiveness Analyses.
- Published in:
- Annals of the American Thoracic Society, 2014, v. 11, n. Supp2, p. S105, doi. 10.1513/AnnalsATS.201309-295RM
- By:
- Publication type:
- Article
A Call for Open-Source Cost-Effectiveness Analysis.
- Published in:
- 2018
- By:
- Publication type:
- Letter
Cost and Cost-effectiveness of Large-scale Screening for Type 1 Diabetes in Colorado.
- Published in:
- 2020
- By:
- Publication type:
- journal article
On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections.
- Published in:
- 2019
- By:
- Publication type:
- journal article
59-LB: The Impact of Glycemic Variability on the Relationship between Hypoglycemia and HbA1c.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-59-LB
- By:
- Publication type:
- Article